Update on clinical trial for hemangiosarcoma treatment from Dr. Dickerson.
Research update from Dr. Volk on prognostic markers for canine mammary cancer.
Continue reading “Research Update Mid-Year 2 CHF 02489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes”
FINAL update from Dr. Arenas indicating a potential vaccine for canine brucellosis has been developed and tested in the laboratory on blood samples. The next step to get this vaccine to market would be to test on actual live dogs.
Dr. Casal and her fellow researchers at UPENN are pleased to report their data now provides them with a marker test for Puppy Eye Syndrome. UPENN will be able to offer this gene test to breeders the beginning of 2020. Prices will be announced before the end of the year.
Additional details of this exciting development in their work are provided in their end-year 2 research update.
Research update for scientific investigation of Diet-Associated dilated cardiomyopathy.
Research update for improving diagnostics for Tick-Borne Disease with genetic sequencing.
Research update for improving diagnostics for Tick-Borne Disease.
Research update from Dr. Breitschwerdt looking at the potential role of the Tick-Borne bacterial infection, bartonella in the initiation and/or progression of hemangiosarcoma.
Research update from Dr. Nicola Mason to profile lymphoma and enable targeted therapy.
Research Update from Dr. Petersen into Tick-Borne Disease.